Oncosil Medical Ltd (OSL) — Cash Flow Reinvestment Rate
Oncosil Medical Ltd (OSL) has a Cash Flow Reinvestment Rate of 0.07x as of June 2015, reinvesting AU$43.85K (capex AU$43.85K ) from operating cash flow of AU$596.28K. Explore Oncosil Medical Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oncosil Medical Ltd Cash Flow Reinvestment Rate (2006–2010)
Historical reinvestment intensity for Oncosil Medical Ltd across 2 annual periods. Explore OSL debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Oncosil Medical Ltd (2006–2010)
Year-by-year capital reinvestment analysis for Oncosil Medical Ltd. For live market cap and broader valuation context, see market value of Oncosil Medical Ltd.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.20x | AU$30.48K | AU$154.35K | AU$30.48K | ▼ -85.8% |
| 2006 | 1.39x | AU$271.11K | AU$195.51K | AU$271.11K | — |